Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain zaps tuned to your wiring: a new hope for depression?

NCT ID NCT07753473

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study investigates whether transcranial magnetic stimulation (TMS), a non-invasive technique that uses magnetic pulses to stimulate brain areas, can influence the coupling between heart and brain activity in individuals with depressive tendencies. Participants will undergo brain scans and receive different types of TMS targeting personalized brain regions, while their brain and heart signals are recorded. The goal is to understand how targeted stimulation affects this heart-brain connection, which could inform future personalized treatments for depression.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcranial magnetic stimulation (TMS) targeting personalized brain regions
What this could lead to
If successful, this could pave the way for more personalized, non-invasive brain stimulation treatments for depression, potentially improving how the brain and heart communicate.
What could go wrong
This is an early-stage study with a small number of participants, so results may not apply broadly. TMS is generally safe but can cause mild discomfort or headache.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 一、Inclusion criteria for the depressed group: 1. Aged 18-30 years; 2. Recent feelings of low mood and presence of depressive symptoms; 3. Physically healthy, with no history of neurological disorders; 4. No participation in other neuromodulation experiments within the past month; 5. Normal hearing and normal (or corrected-to-normal) vision; 6. PHQ-9 score \> 5 and BDI-II score \> 13; 7. Avoidance of staying up late, alcohol consumption, and excessive caffeine intake prior to the experiment; 8. Able and willing to cooperate with the completion of scale assessments. 二、Inclusion criteria for healthy participants: (1) Aged 18-30 years; (2) No significant symptoms of depression and no history of neuropsychiatric disorders; (3) Physically healthy with no history of neurological disorders; (4) No participation in other neuromodulation experiments within the past month; (5) Normal hearing and normal (or corrected-to-normal) vision; (6) PHQ-9 score \< 5 and BDI-II score \< 13; (7) Avoidance of staying up late, alcohol consumption, and excessive caffeine intake prior to the experiment; (8) Able and willing to cooperate with the completion of scale assessments. Exclusion Criteria: 1. History of head trauma (including neurosurgery), stroke, elevated intracranial pressure, or other brain-related disorders; 2. History of epileptic seizures or family history of epilepsy; 3. Receipt of TMS or other neuromodulation stimulation within the past month; 4. Presence of intracranial or internal metallic foreign bodies, electrodes made of silver or gold, or metal prostheses; 5. Presence of devices potentially affected by TMS, such as pacemakers, drug pumps, cochlear implants, or implanted brain stimulators; 6. Severe or recent cardiac, pulmonary, or hematopoietic system disorders, or other neurological diseases; 7. Clinically diagnosed moderate-to-severe depressive disorder; 8. Substance abuse, alcohol dependence, etc.; 9. Current active suicidal ideation or suicidal behavior; Refusal to sign the informed consent form.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depression disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Xidian University

    RECRUITING

    Xi'an, Shaanxi, 71000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.